Feature Channels: Respiratory Diseases and Disorders

Filters close
Released: 27-Feb-2020 5:30 PM EST
How to prepare in the event of a pandemic
University of Alabama at Birmingham

UAB experts provide tips for you to prepare yourself in the event of the spread of COVID-19.

Released: 27-Feb-2020 10:50 AM EST
Tulane researchers developing rapid test for tuberculosis with DOD grant
Tulane University

Led by Tony Hu, the Weatherhead Presidential Chair in Biotechnology Innovation at Tulane University School of Medicine, researchers are now developing a rapid, reliable and highly specific test to allow rapid diagnosis of all forms of Tuberculosis (TB).

Released: 27-Feb-2020 8:00 AM EST
Slumber disruptions caused by obstructive sleep apnea can take a toll on health
Atrium Health Wake Forest Baptist

A study by the American Academy of Sleep Medicine found that while approximately 30 million American adults have obstructive sleep apnea only about 6 million, or 20%, have been properly diagnosed and treated.

Released: 26-Feb-2020 4:00 PM EST
Dr. Donald Sullivan Receives ATS Foundation Research Program/American Lung Association Partner Grant
American Thoracic Society (ATS)

The ATS Foundation Research Program and the American Lung Association have awarded Donald Sullivan, MD, of Oregon Health & Science University a $100,000 Foundation Partner grant. The ATS Foundation Partner Grants provide crucial support to talented investigators from around the world, launching careers dedicated to scientific discovery and better patient care.

Released: 26-Feb-2020 12:25 PM EST
Register to Cover the Latest Science at ATS 2020!
American Thoracic Society (ATS)

The American Thoracic Society will host the world’s leading scientists and clinicians in pulmonary, critical care, and sleep medicine at the ATS 2020 International Conference (ATS 2020).

Released: 26-Feb-2020 11:40 AM EST
No Benefit Found in Using Broad-spectrum Antibiotics as Initial Pneumonia Treatment
University of Utah Health

Doctors who use drugs that target antibiotic-resistant bacteria as a first-line defense against pneumonia should probably reconsider this approach, according to a new study of more than 88,000 veterans hospitalized with the disease. The study found that pneumonia patients given these medications in the first few days after hospitalization fared no better than those receiving standard medical care for the condition.

21-Feb-2020 9:00 AM EST
Comparing PFAS exposures in female firefighters and office workers
American Chemical Society (ACS)

Researchers reporting in ACS’ Environmental Science & Technology have compared PFAS in the serum of female firefighters and female office workers, finding higher levels of three compounds in the firefighters.

   
Released: 25-Feb-2020 11:20 AM EST
WashU Expert: Ingredients for a virus to become a pandemic
Washington University in St. Louis

As of Feb. 25, 2020, the World Health Organization reported 79,339 confirmed cases of novel coronavirus, also known as COVID-19. Thirty-four countries have reported cases, including 2,619 deaths.The WHO has not declared COVID-19 as a pandemic — a situation defined somewhat vaguely by the WHO as “the worldwide spread of a new disease.

Released: 24-Feb-2020 9:55 AM EST
Harvard scientists, Chinese colleagues to collaborate on coronavirus research
Harvard Medical School

Harvard University scientists will collaborate with Chinese colleagues to elucidate the basic biology of the novel coronavirus (COVID-19), and the resulting disease, toward new diagnostic tools, vaccine development and antiviral therapies. The collaboration is part of a $115 million research initiative funded by China Evergrande Group.

Released: 24-Feb-2020 8:00 AM EST
New Tool for an Old Disease: Use of PET and CT Scans May Help Develop Shorter TB Treatment
Johns Hopkins Medicine

Experts believe that tuberculosis, or TB, has been a scourge for humans for some 15,000 years, with the first medical documentation of the disease coming out of India around 1000 B.C.E. Today, the World Health Organization reports that TB is still the leading cause of death worldwide from a single infectious agent, responsible for some 1.5 million fatalities annually. Primary treatment for TB for the past 50 years has remained unchanged and still requires patients to take multiple drugs daily for at least six months. Successful treatment with these anti-TB drugs — taken orally or injected into the bloodstream — depends on the medications “finding their way” into pockets of TB bacteria buried deep within the lungs.

18-Feb-2020 4:00 PM EST
Traditional Biomass Stoves, Used Widely in Developing Nations, Shown to Elevate Indoor Air Pollutants, Cause Lung Inflammation
American Thoracic Society (ATS)

Traditional stoves that burn biomass materials and are not properly ventilated, which are widely used in developing nations where cooking is done indoors, have been shown to significantly increase indoor levels of harmful PM2.5 (miniscule atmospheric particulates) and carbon monoxide (CO) and to stimulate biological processes that cause lung inflammation and may lead to chronic obstructive pulmonary disease (COPD), according to new research published online in the Annals of the American Thoracic Society.

18-Feb-2020 4:05 PM EST
Addition of Immunotherapy to Standard Treatment for Advanced Stage Non-Small Cell Lung Cancer is Safe and Tolerable as First-Line Therapy
Rutgers Cancer Institute

Research from Rutgers Cancer Institute of New Jersey shows administering the immunotherapy drug pembrolizumab together with chemotherapy given at the same time as radiation treatment (chemoradiation) is safe and tolerable as a first-line therapy for patients with stage 3 non-small cell lung cancer (NSCLC).

Released: 20-Feb-2020 8:25 AM EST
أمل جديد لمرضى داء الانسداد الرئوي المزمن بفضل جهاز يُستخدم في المنزل
Mayo Clinic

في ورقة بحثية جديدة نُشِرت بتاريخ 4 فبراير في شبكة JAMA, وصف باحثون من Mayo Clinic فوائد علاج تنفسي منزلي غير باضع ― يشتمل على نوع يُشار إليه بضغط مجرى التنفس الموجب ثنائي المستوى أو BiPAP ― لكثير من المرضى المصابين بداء الانسداد الرئوي المزمن. وذكر الفريق عددًا من الفوائد منها انخفاض الوفيات وانخفاض حالات دخول المستشفيات، وتقليل خطورة التنبيب وتحسن حالات ضيق التنفس وانخفاض عدد زيارات أقسام الطوارئ.

Released: 20-Feb-2020 8:20 AM EST
Nova esperança para pacientes com DPOC, graças a um aparelho que pode ser usado em casa
Mayo Clinic

. Em um novo artigo publicado em 4 de fevereiro pela revista JAMA, os pesquisadores da Mayo Clinic descrevem os benefícios da terapia de ventilação não invasiva em casa, que exerce uma pressão positiva nas vias aéreas em dois níveis, ou BiPAP, para vários pacientes com doença pulmonar obstrutiva crônica (DPOC).

Released: 20-Feb-2020 8:20 AM EST
家用设备可能为COPD患者带来新希望
Mayo Clinic

在2月4日JAMA发布的一篇新论文中,Mayo Clinic的研究人员描述了家庭无创通气治疗对许多慢性阻塞性肺疾病(COPD)患者的益处,其中包括一种被称为双水平气道正压(BiPAP)的治疗。 该团队确定了许多益处,包括降低死亡率、减少住院次数、降低插管风险、改善气短症状和减少急诊次数。

Released: 20-Feb-2020 8:10 AM EST
Neue Hoffnung für COPD-Patienten mit Gerät für zu Hause möglich
Mayo Clinic

In einer neuen, am 4. Feb. in JAMA veröffentlichten Arbeit beschreiben Forscher von Mayo Clinic die Vorzüge einer nicht-invasiven Beatmungstherapie zu Hause ― die einen Typ umfasst, der auch als BiPAP bezeichnet wird ― für viele Patienten mit chronisch obstruktiver Lungenkrankheit (COPD).

Released: 20-Feb-2020 8:10 AM EST
Un nouvel espoir pour les patients atteints de BPCO avec un dispositif à domicile
Mayo Clinic

Dans un nouvel article publié le 4 février dans JAMA, les chercheurs de Mayo Clinic décrivent les avantages de la thérapie de ventilation non invasive à domicile ; celle-ci comprend un dispositif appelé dispositif à pression positive biniveau, ou BiPAP, destiné à de nombreux patients atteints de bronchopneumopathie chronique obstructive (BPCO).



close
2.50631